X

ANGO

Angiodynamics Inc (ANGO) Q2 2026 Earnings Call Transcript

Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%

Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of…

Earnings Summary: AngioDynamics (ANGO) reports Q1 loss; sales up 12.2%

Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Thursday reported a net loss for the first quarter of 2026. Revenues…

AngioDynamics (ANGO) Q3 2025 loss narrows; sales down 4%

Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) Wednesday reported a narrower net loss for the third quarter of 2025. Revenues…

AngioDynamics (ANGO) reports net loss for Q2 2025; sales drop 8%

AngioDynamics Inc. (NASDAQ: ANGO) reported a net loss for the second quarter of 2025 as the medical device company’s revenues…

Angiodynamics Inc (ANGO) Q4 2023 Earnings Call Transcript

Angiodynamics Inc (NASDAQ: ANGO) Q4 2023 earnings call dated Jul. 12, 2023 Corporate Participants: Jim Clemmer — Chief Executive Officer Steve Trowbridge — Chief…

Earnings: AngioDynamics (ANGO) reports higher adj. profit for Q4; revenue up 5%

Medical device company AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported an increase in adjusted profit for the fourth quarter of…

AngioDynamics Inc. (ANGO) Q3 2023 Earnings Call Transcript

AngioDynamics Inc. (NASDAQ: ANGO) Q3 2023 earnings call dated Mar. 30, 2023 Corporate Participants: Jim Clemmer — President and Chief Executive Officer…

Why AngioDynamics (ANGO) deserves a place on investors’ watchlist

The market reopening has created a conducive atmosphere to carry out elective medical procedures which were deferred on a large…

Angiodynamics Inc (ANGO) Q1 2023 Earnings Call Transcript

Angiodynamics Inc (NASDAQ: ANGO) Q1 2023 earnings call dated Oct. 06, 2022 Corporate Participants: Jim Clemmer — President and Chief Executive Officer…